Shares of Moderna MRNA rose nearly 13% on Friday after the company unveiled a long-term strategy to transform itself from a ...

Cancer was a key focus, with programs targeting solid tumors, Lynch syndrome, melanoma, and non-small cell lung cancer.

The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...

Moderna stock soars on positive updates during the Science Day presentation. Jefferies sees significant further upside in ...

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

Provides broad overview of Company's research and early development programs expected to continue to fuel future ...

By Julie Steenhuysen CHICAGO, June 9 (Reuters) - Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly ...

Moderna Inc. Chief Executive Officer Stephane Bancel said he sees the pending launch of a planned flu vaccine as a chance to ...

A first-of-its-kind flu shot is one step closer to being available to the public after a Food and Drug Administration (FDA) ...

A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of ...

By Christy Santhosh and Mariam Sunny June 18 (Reuters) - Advisers to the U.S. Food and Drug Administration on Thursday backed ...

Moderna's novel vaccine was at the center of dustup with agency earlier this year ...